• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Resverlogix Corp

+ Add to Watchlist


0.8100 CAD 0.0200 2.41%

As of 12:27:18 ET on 07/11/2014.

Company Profile for Resverlogix Corp (RVX)

Resverlogix Corp. is a biotechnology company focused on developing therapies for unmet medical needs. The Company concentrates on cardiovascular disease, cancer, and fibrotic conditions.

Contact Information

Resverlogix Corp

202, 279 Midpark Way SE
Calgary, AB T2X 1M2
Phone: 1-403-254-9252
Fax: 1-403-256-8495

Key Executives for Resverlogix Corp (RVX)

Donald J McCaffreyPresident/CEO/SecretaryAaron Bradley Cann "Brad"Chief Financial Officer
Allan GordonSenior VP:Clinical DevelopmentGregory WagnerSenior VP:Research & Dev
Peter YoungSenior VP:Discovery Research

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil